BGM earnings: real EPS beat/miss history, P/E -1.41. Updated 2026-07-23.
BGM Group (BGM) Research Hub
BGM Group (BGM) trades on NASDAQ, CN in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 0.263 USD (-3.70%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.41, market cap 0.06B. This hub links to the full technical, earnings and options research available for BGM.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, CN |
| Last close | 0.263 USD (-3.70%) |
| 52-week range | 0.2309 USD – 0.5 USD |
| Trend regime | Range |
| 14-day RSI | 42.1 (Bearish) |
| Trailing P/E | -1.41 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
Available research for BGM
Covered Call on BGM: how it works, illustrative setup around the real 0.263 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BGM: how it works, illustrative setup around the real 0.263 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BGM: how it works, illustrative setup around the real 0.263 USD price, max profit/loss, breakeven and when to use it. Educational.
BGM technical analysis: range, last 0.263 USD, RSI 42.1, 52w range 0.2309 USD–0.5 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is BGM in?
BGM Group (BGM) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, CN.
Is BGM in an uptrend or downtrend?
As of 2026-09-11, BGM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BGM's trailing P/E ratio?
BGM's trailing P/E is -1.41, with a market cap of 0.06B. See the earnings research page for full valuation detail.